跳至主要内容
临床试验/NCT05401422
NCT05401422Unknown不适用

Efficacy and Safety of Combining Doxycycline With Pulsed Dye Laser Versus Topical Brimonidine 0.33% in the Treatment of Erythematotelangiectatic Rosacea: a Comparative Clinical and Dermoscopic Study

Cairo University0 个研究点目标入组 45 人开始时间: 2022年5月25日最近更新:
适应症

试验速览

阶段
不适用
入组人数
45
主要终点
Clinical erythema assessment scale

研究概览

简要总结

Rosacea is a chronic and relapsing inflammatory cutaneous disorder with highly variable prevalence worldwide.

详细描述

In our study, we will compare the safety, efficacy, and adverse effects of low-dose oral doxycycline alone versus combined with pulsed dye laser or topical brimonidine in treating erythematotelangiectatic rosacea in an attempt to build a treatment strategy in a disease with complex pathogenesis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with current erythematotelangiectatic rosacea

排除标准

  • Pregnant females. 2-Patients on systemic steroids. 3-Patients complaining of other dermatological disorders mainly photosensitive cutaneous disorder.
  • 4- Patients receiving any systemic treatment including retinoids for the previous 1 month or any topical treatment for the previous 2 weeks or any laser sessions for the previous 3months for erythematotelangiectatic rosacea at least.

结局指标

主要结局

Clinical erythema assessment scale

时间窗: 3 months

clinical scale

次要结局

  • Thickness of capillaries by dermoscope(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hagar El Sayed

Dr

Cairo University

相似试验